FDA.reportPublic FDA data

24 HR pregabalin 165 MG Extended Release Oral Tablet [Lyrica]

RxCUI
1994389
RxNorm name
24 HR pregabalin 165 MG Extended Release Oral Tablet [Lyrica]
Display name
24 HR pregabalin 165 MG Extended Release Oral Tablet [Lyrica]
Full name
24 HR pregabalin 165 MG Extended Release Oral Tablet [Lyrica]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lyrica CRPREGABALINViatris Specialty LLCf280bbd8-2af2-444a-bd96-e409337ca6dd2026-03-12Warnings, Adverse reactionsExact identifier
rxcui: 1994389

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f280bbd8-2af2-444a-bd96-e409337ca6ddLyrica CR 165 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR pregabalin 165 MG Extended Release Oral Tablet [Lyrica] [SBD] · 24 HR Lyrica 165 MG Extended Release Oral Tablet [SY]37These highlights do not include all the information needed to use LYRICA CR safely and effectively. See full prescribing information for LYRICA CR. LYRICA ® CR (pregabalin) extended-release tablets, for oral use, CV Initial U.S. Approval: 200420260312